<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en-US" data-colors-preset="contrast" data-primary-color="#307FFF"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="UTF-8"><meta name="robots" content="noindex">  <meta name="built-on" content="2024-01-01T12:25:13.2478002"><meta name="build-number" content="${buildNumber}">       <title>大行评级｜海通国际：首予和黄医药H股&ldquo;优于大市&rdquo;评级 目标价45.09港元 | 20231016</title><script id="virtual-toc-data" type="application/json">[]</script><script id="topic-shortcuts" type="application/json"></script><link href="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.css" rel="stylesheet">   <link rel="apple-touch-icon" sizes="180x180" href="https://jetbrains.com/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="https://jetbrains.com/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="https://jetbrains.com/favicon-16x16.png"><link rel="manifest" href="https://jetbrains.com/site.webmanifest"><link rel="mask-icon" href="https://jetbrains.com/safari-pinned-tab.svg" color="#000000"><meta name="msapplication-TileColor" content="#000000"/><meta name="msapplication-TileImage" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-144x144.png"/><meta name="msapplication-square70x70logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-70x70.png"/><meta name="msapplication-square150x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-150x150.png"/><meta name="msapplication-wide310x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x150.png"/><meta name="msapplication-square310x310logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x310.png"/>  <meta name="image" content=""><!-- Open Graph --><meta property="og:title" content="大行评级｜海通国际：首予和黄医药H股&ldquo;优于大市&rdquo;评级 目标价45.09港元 | 20231016"/><meta property="og:description" content=""/><meta property="og:image" content=""/><meta property="og:site_name" content="20231016 Help"/><meta property="og:type" content="website"/><meta property="og:locale" content="en_US"/><meta property="og:url" content="2187.html"/><!-- End Open Graph --><!-- Twitter Card --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content=""><meta name="twitter:title" content="大行评级｜海通国际：首予和黄医药H股&ldquo;优于大市&rdquo;评级 目标价45.09港元 | 20231016"><meta name="twitter:description" content=""><meta name="twitter:creator" content=""><meta name="twitter:image:src" content=""><!-- End Twitter Card --><!-- Schema.org WebPage --><script type="application/ld+json"> { "@context": "http://schema.org", "@type": "WebPage", "@id": "2187.html#webpage", "url": "2187.html", "name": "大行评级｜海通国际：首予和黄医药H股&ldquo;优于大市&rdquo;评级 目标价45.09港元 | 20231016", "description": "", "image": "", "inLanguage":"en-US" }</script><!-- End Schema.org --><!-- Schema.org WebSite --><script type="application/ld+json"> { "@type": "WebSite", "@id": "/#website", "url": "/", "name": "20231016 Help" }</script><!-- End Schema.org --></head>      <body data-id="2187" data-main-title="大行评级｜海通国际：首予和黄医药H股&ldquo;优于大市&rdquo;评级 目标价45.09港元" data-article-props="{&quot;seeAlsoStyle&quot;:&quot;links&quot;}"  data-template="article"  data-breadcrumbs=""  >   <div class="wrapper"><main class="panel _main"><header class="panel__header"><div class="container"><h3>20231016  Help</h3><div class="panel-trigger"></div></div></header><section class="panel__content"><div class="container"><article class="article" data-shortcut-switcher="inactive"><h1 data-toc="2187"   id="2187.md">大行评级｜海通国际：首予和黄医药H股&ldquo;优于大市&rdquo;评级 目标价45.09港元</h1>  <p id="29281bf7_15"><span class="control" id="29281bf7_16">2023-10-16 08:43</span></p><p id="29281bf7_17"><span class="control" id="29281bf7_18">https://www.gelonghui.com/live/1249047</span></p><p id="29281bf7_19">格隆汇10月16日｜海通国际发表报告指，和黄医药两款新药授权跨国药企，创新药龙头迈向盈利之路。公司管线具有全球创新价值，呋喹替尼携手武田探索胃肠道肿瘤、赛沃替尼携手阿斯利康探索肺癌。第二波创新管线聚焦血液疾病，Best-inclass 索乐匹尼布治疗2L+ ITP已达到III期主要终点。公司预计2025年实现盈亏平衡。 海通国际首予和黄医药&ldquo;优于大市&rdquo;评级，目标价45.09港元。预计公司2023至2025年风险调整后的收入分别为799/783/1,071百万美元，按年+87/-2/+37%。随公司管线优先级顺序调整以及开展国际商业合作，该行认为公司国内研发费用将保持合理增长。海通国际预计公司2023至2025年纯利分别为+87/-7/+168百万美元，并于2025年达到盈亏平衡。公司现金8.56亿美元，该行认为盈亏平衡前暂无融资压力。</p><div class="last-modified"> Last modified: 01 一月 2024</div><div data-feedback-placeholder="true"></div><div class="navigation-links _bottom">  <a class="navigation-links__prev" href="2188.html">片仔癀：Q3净利润8.64亿元，同比增17.03%</a>   <a class="navigation-links__next" href="2186.html">香港中文大学陶然：建议住宅70年产权改为永久</a>  </div></article><div id="disqus_thread"></div></div></section></main></div>  <script src="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.js"></script></body></html>